Who owns Arca Biopharma Inc?
- Ticker: ABIO
- CUSIP Number: 00211y506
Tip: Access positions for across all investors
Analyze quarterly positions in Arca Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Arca Biopharma stock
Who bought or sold Arca Biopharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cable Car Capital | 4.0M | $15M | 0% | Jun 2024 |
|
| Henderson Group | 1.4M | $5.2M | 100% | Jun 2024 |
|
| Morgan Stanley | 650k | $2.5M | 100% | Jun 2024 |
|
| Vanguard Group | 454k | $1.7M | 0% | Jun 2024 |
|
| BlackRock | 248k | $950k | 7% | Jun 2024 |
|
| State Street Corporation | 60k | $229k | 0% | Jun 2024 |
|
| Tower Research Capital | 344.00 | $1.3k | -89% | Jun 2024 |
|
| Qube Research & Technologies | 50.00 | $192.000000 | 0% | Jun 2024 |
|
Who sold out of Arca Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Avidity Partners Management | Jun 2024 | 1.0M | $3.8M |
| VR Adviser | Jun 2024 | 866k | $3.3M |
| Cowen And Company | Jun 2024 | 700k | $2.7M |
| Commodore Capital | Jun 2024 | 414k | $1.6M |
| Geode Capital Management | Jun 2024 | 162k | $620k |
| Renaissance Technologies | Jun 2024 | 73k | $280k |
| Affinity Asset Advisors | Jun 2024 | 73k | $278k |
| Dimensional Fund Advisors | Jun 2024 | 43k | $163k |
| Standard Life Aberdeen | Jun 2024 | 33k | $124k |
| Citadel Advisors | Jun 2024 | 32k | $121k |
| Cubist Systematic Strategies | Jun 2024 | 28k | $106k |
| Northern Trust | Mar 2024 | 21k | $37k |
| Susquehanna International | Jun 2024 | 20k | $75k |
| Charles Schwab Investment Management | Jun 2024 | 15k | $57k |
| Group One Trading | Jun 2024 | 7.1k | $27k |
| Activest Wealth Management | Jun 2024 | 2.0k | $7.7k |
| Simplex Trading | Jun 2024 | 275.00 | $1.0k |
| Parallel Advisors | Jun 2024 | 244.00 | $935.008000 |
| Bank of America Corporation | Jun 2024 | 151.00 | $579.054800 |